Transcripts Exagen Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-28 EDT			5-day change	1st Jan Change
1.82 ^USD	-1.62%		-7.14%	-8.54%

05-14	Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating	MT
05-13	Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Transcript : Exagen Inc., Q1 2024 Earnings Call, May 13, 2024	05-13
Transcript : Exagen Inc., Q4 2023 Earnings Call, Mar 18, 2024	03-18
Transcript : Exagen Inc., Q3 2023 Earnings Call, Nov 13, 2023	11-13
Transcript : Exagen Inc., Q2 2023 Earnings Call, Aug 07, 2023	23-08-07
Transcript : Exagen Inc., Q1 2023 Earnings Call, May 15, 2023	23-05-15
Transcript : Exagen Inc., Q4 2022 Earnings Call, Mar 20, 2023	23-03-20
Transcript : Exagen Inc., Q3 2022 Earnings Call, Nov 14, 2022	22-11-14
Transcript : Exagen Inc., Q2 2022 Earnings Call, Aug 04, 2022	22-08-04
Exagen Inc. Provides Revenue Guidance for the Year of 2022	22-08-04	CI
Transcript : Exagen Inc., Q1 2022 Earnings Call, May 11, 2022	22-05-11
Transcript : Exagen Inc., Q4 2021 Earnings Call, Mar 22, 2022	22-03-22
Exagen Inc. Provides Revenue Guidance for the Full Year 2022	22-03-22	CI
Transcript : Exagen Inc., Q3 2021 Earnings Call, Nov 10, 2021	21-11-10
Exagen Inc. Provides Revenue Guidance the Full Year 2021	21-11-10	CI
Transcript : Exagen Inc., Q2 2021 Earnings Call, Aug 09, 2021	21-08-09
Exagen Inc. Re-Affirms Revenue Guidance for the Year 2021	21-08-09	CI
Transcript : Exagen Inc., Q1 2021 Earnings Call, May 11, 2021	21-05-11
Exagen Inc. Provides Earnings Guidance for the Fiscal Year 2021	21-05-11	CI
Transcript : Exagen Inc., Q4 2020 Earnings Call, Mar 16, 2021	21-03-16
Exagen Inc. Provides Revenue Guidance for the Full Year 2021	21-03-16	CI

No results for this search